Back to calendar
Immunovant, Inc. (IMVT) Earnings
IMVT reports earnings on Monday, November 9, 2026
earnings report
November 9, 2026
Q3 2026
Est. EPS: $-0.74
Actual EPS: $-0.75
Company overview
Market Cap$5.9B
SectorHealth Technology
IndustryBiotechnology